Open Access Repository

Effect of statin therapy on cognitive decline and incident dementia in older adults

Zhou, Z ORCID: 0000-0002-0835-8686, Ryan, J, Ernst, ME, Zoungas, S, Tonkin, AM, Woods, RL, McNeil, JJ, Reid, CM, Curtis, AJ, Wolfe, R, Wrigglesworth, J, Shah, RC, Storey, E, Murray, A, Orchard, SG and Nelson, MR ORCID: 0000-0001-9941-7161 2021 , 'Effect of statin therapy on cognitive decline and incident dementia in older adults' , Journal of the American College of Cardiology, vol. 77, no. 25 , pp. 3145-3156 , doi: 10.1016/j.jacc.2021.04.075.

Full text not available from this repository.


Background: The neurocognitive effect of statins in older adults remain uncertain.Objectives: The aim of this study was to investigate the associations of statin use with cognitive decline and incident dementia among older adults.Methods: This analysis included 18,846 participants ≥65 years of age in a randomized trial of aspirin, who had no prior cardiovascular events, major physical disability, or dementia initially and were followed for 4.7 years. Outcome measures included incident dementia and its subclassifications (probable Alzheimer's disease, mixed presentations); mild cognitive impairment (MCI) and its subclassifications (MCI consistent with Alzheimer's disease, other MCI); and changes in domain-specific cognition, including global cognition, memory, language and executive function, psychomotor speed, and the composite of these domains. Associations of baseline statin use versus nonuse with dementia and MCI outcomes were examined using Cox proportional hazards models and with cognitive change using linear mixed-effects models, adjusting for potential confounders. The impact of statin lipophilicity on these associations was further examined, and effect modifiers were identified.Results: Statin use versus nonuse was not associated with dementia, MCI, or their subclassifications or with changes in cognitive function scores over time (p > 0.05 for all). No differences were found in any outcomes between hydrophilic and lipophilic statin users. Baseline neurocognitive ability was an effect modifier for the associations of statins with dementia (p for interaction Conclusions: In adults ≥65 years of age, statin therapy was not associated with incident dementia, MCI, or declines in individual cognition domains. These findings await confirmation from ongoing randomized trials.

Item Type: Article
Authors/Creators:Zhou, Z and Ryan, J and Ernst, ME and Zoungas, S and Tonkin, AM and Woods, RL and McNeil, JJ and Reid, CM and Curtis, AJ and Wolfe, R and Wrigglesworth, J and Shah, RC and Storey, E and Murray, A and Orchard, SG and Nelson, MR
Keywords: aged, cognitive function, dementia, hydroxymethylglutaryl CoA reductase inhibitors, statins
Journal or Publication Title: Journal of the American College of Cardiology
Publisher: Elsevier Science Inc
ISSN: 0735-1097
DOI / ID Number: 10.1016/j.jacc.2021.04.075
Copyright Information:

Copyright by the American College of Cardiology Foundation

Related URLs:
Item Statistics: View statistics for this item

Actions (login required)

Item Control Page Item Control Page